Workflow
Cryoport(CYRX)
icon
Search documents
Cryoport(CYRX) - 2023 Q4 - Annual Report
2024-03-12 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Nevada 88-0313393 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 112 Westwood Place, Suite 350 Brentwood, TN 37027 (Address of principal executive offices, including zip code) FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 □ TRANSITION REPORT PURSUANT TO SECTION 1 ...
Cryoport(CYRX) - 2023 Q4 - Annual Results
2024-03-11 16:00
Exhibit 99.1 Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results "Product revenues were lower than historical levels; however, MVE Biological Solutions' revenue began to stabilize in the latter part of the year. Moreover, MVE continues to be a strong business unit, which has generated considerable free cash flow and maintained margins on its product revenue. "Throughout 2023, we made targeted investments in our business and formed strategic relationships to further position ourselves for co ...
Analysts Estimate CryoPort, Inc. (CYRX) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research· 2024-02-15 16:06
Wall Street expects a year-over-year decline in earnings on lower revenues when CryoPort, Inc. (CYRX) reports results for the quarter ended December 2023. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the sto ...
Should You Buy CryoPort, Inc. (CYRX) After Golden Cross?
Zacks Investment Research· 2024-02-13 15:56
After reaching an important support level, CryoPort, Inc. (CYRX) could be a good stock pick from a technical perspective. CYRX recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving av ...
Cryoport(CYRX) - 2023 Q3 - Earnings Call Transcript
2023-11-09 05:18
Cryoport, Inc. (NASDAQ:CYRX) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Todd Fromer - Investor Relations Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development and Investor Relations Conference Call Participants Paul Knight - KeyBanc David Saxon - Needham John Sourbeer - UBS Jacob Johnson - Stephens Yuan Zhi - B. Riley David Larsen - BTIG Brand ...
Cryoport(CYRX) - 2023 Q3 - Quarterly Report
2023-11-08 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 88-0313393 ...
Cryoport(CYRX) - 2023 Q2 - Earnings Call Transcript
2023-08-10 02:42
Cryoport, Inc. (NASDAQ:CYRX) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Corporate Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development and Investor Relations Conference Call Participants Puneet Souda - SVB Securities David Saxon - Needham & Company Lucas Beaumont - UBS David Larsen - BTIG ...
Cryoport(CYRX) - 2023 Q2 - Quarterly Report
2023-08-08 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) (949) 470-2300 (Regist ...
Cryoport(CYRX) - 2023 Q1 - Earnings Call Transcript
2023-05-05 07:23
Cryoport, Inc. (NASDAQ:CYRX) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Todd Fromer - Investor Relations Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development and Investor Relations Conference Call Participants Puneet Souda - SVB Securities Matthew Stanton - Jefferies John Sourbeer - UBS David Larsen - BTIG Paul Knight - KeyBanc Capital David Saxon ...
Cryoport(CYRX) - 2023 Q1 - Quarterly Report
2023-05-03 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 88-0313393 (St ...